Institutional investors purchased a net $6.6 million shares of INO during the quarter ended September 2017, and now own 32.39% of the total float, a percentage that is typical for companies in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SSGA FUNDS MANAGEMENT, INC. Bought 1.6 Million shares of Inovio Pharmaceuticals In...
BLACKROCK FUND ADVISORS Bought 1.1 Million shares of Inovio Pharmaceuticals In...